Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia. - Wikidata - wikimedia - TriplyDB

Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.

Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.

http://www.wikidata.org/entity/Q37329147

about

Efficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply beta-lactam-resistant variant of Pseudomonas aeruginosa stably derepressed for beta-lactamase production.Development of resistance to cephalosporins in clinical strains of Citrobacter spp.The changing ecology of hospital bacteria and the selective role of cephalosporins Detection of resistance due to inducible beta-lactamase in Enterobacter aerogenes and Enterobacter cloacae.Evaluation of the cefonicid disk test criteria, including disk quality control guidelines In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents.Resistance of Pseudomonas aeruginosa to new beta-lactamase-resistant beta-lactams.Antagonism of carbenicillin and cefamandole by cefoxitin in treatment of experimental infections in mice.Epidemiological typing of Enterobacter aerogenes.Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins.Influence of clindamycin on derepression of beta-lactamases in Enterobacter spp. and Pseudomonas aeruginosa

P2860

Q35574922-2911D0E2-44B8-4E22-B663-1FFAB1A195E5 Q35759876-31998951-4AB0-43D4-8A22-10C9692E22B4 Q36505127-A27BCD37-2E23-49B7-AA63-304199BADC7B Q37093946-A66EDABC-FE59-482D-B801-B785C1AE750B Q37303343-BFE3F8FC-86E8-4403-87CC-801E9ED9B841 Q39819588-8072B9C7-4EC1-41AE-AD1F-30BE7450FEE0 Q39849040-6382963F-1DD7-4989-905A-CE4245468AAB Q39857268-F0580526-EEEB-4F78-927A-029216B48574 Q40198827-683FD255-1481-4ED8-8EAF-55B51EA19410 Q41956941-EDBD559E-BDA3-485E-841C-9E7A1DB8392F Q42091897-A6ED8C11-4C14-455C-A36E-EAA4DE34FEA9

P2860

Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.

http://www.wikidata.org/entity/Q37329147

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 1980

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.

@en

Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.

@nl

type

label

Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.

@en

Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.

@nl

prefLabel

Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.

@en

Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.

@nl

P1433

Q37329147-CE863E4F-AD5E-40B3-882F-07EEC887D752

P1476

Q37329147-C95423CD-819A-4F23-B8BA-40E03DE7C67C

P2093

Q37329147-13C5C252-98E6-4C5B-8C4E-4F1208D4D7CA

Q37329147-3AAFD20B-1ED7-4209-8931-08C31BD0CC69

P2860

Q37329147-39CDBEFF-2D37-481D-AA1A-EDE6E12BB646

Q37329147-457AD264-A756-4C4A-BAA7-CB159667091E

Q37329147-50190BB1-888B-4D4D-9B16-99DE6E1E4845

Q37329147-56067132-7D41-40E0-AFEA-533B517BCAA8

Q37329147-653E35C9-8F06-4FD7-B91E-87330D76410D

Q37329147-6F465939-AD11-4691-BFD6-520A68B95600

Q37329147-818D9EA0-B9C7-4DCD-BA44-2E38A35ABC70

Q37329147-96086965-5B6B-40FF-BEE3-9C86AAF6F389

Q37329147-ADDB2356-7B47-481F-A683-7F2A5EEFBF55

Q37329147-D8387945-9B32-4354-A400-5340C2E3EECB

P304

Q37329147-6B03B01A-B916-4E25-98B9-F539541E4D2B

P31

Q37329147-58BDDA5A-2B6E-4EAC-A7AB-B0C17E869A5D

P407

Q37329147-F9E351DD-F946-4A22-94A1-32A5AA6C5AD1

P433

Q37329147-501FAB2A-5818-4C5E-BD0A-40852F8B5C58

P478

Q37329147-6CF2B1C5-05E9-48CB-BD80-5330FA2BFF63

P577

Q37329147-FB90C6EB-648B-47DA-B71D-070BF4629F80

P698

Q37329147-C17C5F7B-53D3-41F8-9218-6F6639F10EE8

P932

Q37329147-ED8F0A9A-E509-4DDE-9EA7-412DB9B3FE5C

P1433

Journal of Clinical Microbiology

P1476

Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.

@en

P2093

Beckwith DG

http://www.w3.org/2001/XMLSchema#string

Jahre JA

http://www.w3.org/2001/XMLSchema#string

P2860

Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases

Standardization of the Analytab Enteric (API 20E) system to increase accuracy and reproducibility of the test for biotype characterization of bacteria.

Lack of correlation between beta-lactamase production and susceptibility to cefamandole or cefoxitin among spontaneous mutants of Enterobacteriaceae.

Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.

Carbenicillin plus cefamandole in the treatment of infections in patients with cancer.

Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.

Susceptibility of Enterobacter to cefamandole: evidence for a high mutation rate to resistance.

Substrate inhibition of beta-lactamases, a method for predicting enzymatic stability of cephalosporins

Cefamandole nafate therapy of respiratory tract, skin, and soft tissue infections in 74 patients.

Gram-negative bacteremia of long duration. Clinical study of 29 patients.

P304

517-520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

1980-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

6968320

http://www.w3.org/2001/XMLSchema#string

P932

273627

http://www.w3.org/2001/XMLSchema#string